Treatment of toxic epidermal necrolysis by burn units: another market or another threat?

M H Jordan; M S Lewis; J G Jeng; J M Rees

doi:10.1097/00004630-199111000-00015

Treatment of toxic epidermal necrolysis by burn units: another market or another threat?

J Burn Care Rehabil. 1991 Nov-Dec;12(6):579-81. doi: 10.1097/00004630-199111000-00015.

Authors

M H Jordan¹, M S Lewis, J G Jeng, J M Rees

Affiliation

¹ Burn Center, Washington Hospital Center, DC 20010.

PMID: 1779014
DOI: 10.1097/00004630-199111000-00015

Abstract

A survey of burn care facilities in the United States has provided information regarding the treatment of toxic epidermal necrolysis and related diseases in burn units. The survey suggests that a disproportionate share (12% to 15%) of the projected number of cases of toxic epidermal necrolysis that occur annually are being transferred to the 2% of United States hospitals that have burn units. Because of the potential for a complex hospital course and extended length of stay, treatment of these patients in a prospective payment system poses a significant fiscal threat to hospitals with burn units.

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Burn Units / economics
Burn Units / statistics & numerical data*
Humans
Medicare Part A
Outliers, DRG / statistics & numerical data*
Prospective Payment System
Referral and Consultation / statistics & numerical data
Stevens-Johnson Syndrome* / epidemiology
Stevens-Johnson Syndrome* / therapy
Surveys and Questionnaires
United States / epidemiology